Hot-selling Hifu Fda - YAG Fractional Laser HS-282 – Apolo
Hot-selling Hifu Fda - YAG Fractional Laser HS-282 – Apolo Detail:

2940nm Er:YAG laser was chosen due to its high ablation efficiency. Because of high absorption in target chromophore water at the 2940nm wavelength, the skin will be quickly heated up and instantly peeled off with very little thermal energy. The energy features a shallow exposure depth; therefore the affected part can be healed almost instantly. Apply for skin resurfacing, melasma, wrinkles and fine lines, wart and nevus removal.
Product detail pictures:


Related Product Guide:
High-intensity focused ultrasound provides noninvasive venous treatment | High Intensity Focused Ultrasound Hifu
Are laser and LED light therapy treatments good for your skin? | Rf Tube Fractional Co2 Laser Burn Scar Removal
Fast and great quotations, informed advisers to help you choose the correct solution that suits all your requirements, a short creation time, responsible top quality manage and distinct providers for paying and shipping affairs for Hot-selling Hifu Fda - YAG Fractional Laser HS-282 – Apolo, The product will supply to all over the world, such as: Nairobi , French , Sierra Leone , So that you can utilize the resource from the expanding info in international trade, we welcome shoppers from everywhere on-line and offline. In spite of the good quality solutions we provide, effective and satisfying consultation service is supplied by our professional after-sale service team. Product lists and detailed parameters and any other info weil be sent to you timely for your inquiries. So you should make contact with us by sending us emails or call us if you have any questions about our corporation. ou may also get our address info from our web page and come to our company to get a field survey of our merchandise. We've been confident that we have been going to share mutual achievement and create strong co-operation relations with our companions in this marketplace. We're searching forward for your inquiries.









